{"url":"https://lda.senate.gov/api/v1/filings/df671db5-3d9b-4e93-b2e7-61d7bbfa52e7/","filing_uuid":"df671db5-3d9b-4e93-b2e7-61d7bbfa52e7","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2013,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/df671db5-3d9b-4e93-b2e7-61d7bbfa52e7/print/","filing_document_content_type":"text/html","income":null,"expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"JOHN M. ENGEL, ESQ.","dt_posted":"2013-04-22T09:20:17.300000-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"2401 Pennsylvania Avenue, N.W.","registrant_address_2":"Suite #310","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20037","registrant":{"id":400461292,"url":"https://lda.senate.gov/api/v1/registrants/400461292/","house_registrant_id":null,"name":"ENGEL & NOVITT, LLP","description":"A District of Columbia Limited Liability Partnership law firm providing legal services.","address_1":"2401 Pennsylvania Avenue, N.W.","address_2":"Suite #310","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20037-1730","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JOHN M. ENGEL, ESQ.","contact_telephone":"+1 202-207-3303","dt_updated":"2022-04-06T16:07:29.762427-04:00"},"client":{"id":191445,"url":"https://lda.senate.gov/api/v1/clients/191445/","client_id":24,"name":"TRYGG PHARMA, INC.","general_description":"Pharmaceutical research and development.","client_government_entity":false,"client_self_select":false,"state":"VA","state_display":"Virginia","country":"US","country_display":"United States of America","ppb_state":null,"ppb_state_display":null,"ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2012-10-25"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"FDA regulatory issues","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":49220,"prefix":"mr","prefix_display":"MR.","first_name":"JOHN","nickname":null,"middle_name":"M.","last_name":"ENGEL","suffix":"esq","suffix_display":"ESQ"},"covered_position":null,"new":false}],"government_entities":[{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}